Sponsor or institution
Clinical trials and research at Xynomic Pharmaceuticals, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Xynomic Pharmaceuticals, Inc. that are recruiting, at sites in 6 countries (most in China (2), Italy (1), Poland (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Evaluating oral abexinostat for patients with relapsed or refractory DLBCL
This study is testing if an oral medication called abexinostat can help people with relapsed or hard-to-treat diffuse large B-cell lymphoma feel better after trying other treatments.
-
Combining pazopanib with abexinostat for advanced kidney cancer
This study is testing whether combining two drugs, pazopanib and abexinostat, can help people with advanced kidney cancer live longer without their disease getting worse compared to just taking pazopanib alone.
Quick answers
How many clinical trials run by Xynomic Pharmaceuticals, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (2 trials), Italy (1 trial), Poland (1 trial), South Korea (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.